<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral vascular amyloid deposits, <z:hpo ids='HP_0100256'>senile plaques</z:hpo> and <z:hpo ids='HP_0002185'>neurofibrillary tangles</z:hpo> have been found in subcortical arteriosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (<z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger disease</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>A mouse antiserum, prepared against a 43-amino acid synthetic <z:chebi fb="7" ids="16670">peptide</z:chebi> homologous to the amyloid beta-protein of <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (anti-SP43), revealed immunoreactive amyloid deposits in meningeal and intracortical blood vessels, <z:hpo ids='HP_0100256'>senile plaques</z:hpo>, intraneuronal amyloid and preamyloid in a neuropathologically confirmed case of <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger disease</z:e> previously reported to have cerebral vascular amyloid deposits </plain></SENT>
<SENT sid="2" pm="."><plain>These lesions contained <z:chebi fb="0" ids="35722">sulfated glycosaminoglycans</z:chebi> as determined by the Alcian blue/critical electrolyte concentration method </plain></SENT>
<SENT sid="3" pm="."><plain>Similar findings were not observed in a case of <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger</z:e> <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> without cerebral amyloid deposits </plain></SENT>
<SENT sid="4" pm="."><plain>Our study indicates that amyloidotic lesions in <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger</z:e> <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> with cerebral amyloid deposits contain amyloid beta-protein and <z:chebi fb="0" ids="35722">sulfated glycosaminoglycans</z:chebi> </plain></SENT>
</text></document>